Evidence map›Paper›PMID 28332504›Full record

ArticleNature communications2017

Correspondence: Oncogenic MYC persistently upregulates the molecular clock component REV-ERBα.

Brian J Altman, Annie L Hsieh, Arvin M Gouw, Chi V Dang

Abstract readLetter
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Berberine alleviates alcoholic liver diseaseactivating intestinal nuclear receptor subfamily 1 group D member 1.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. MYC-Associated Factor MAX is a Regulator of the Circadian Clock.International journal of molecular sciences · 2020
    Article
  12. Circadian Clocks and Cancer: Timekeeping Governs Cellular Metabolism.Trends in endocrinology and metabolism: TEM · 2019
    Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Brian J AltmanAbramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.ORCID 0000-0002-3954-4916
Annie L HsiehAbramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Arvin M GouwAbramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Chi V DangAbramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

Funding

C-MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERSR01CA057341 · NCI · WISTAR INSTITUTE · PI DANG, CHI V. · 1992 to 2021
$8.3M
MYC--TRANSCRIPTION AND INTERACTION WITH P107R01CA051497 · NCI · WISTAR INSTITUTE · PI DANG, CHI V. · 1995 to 2025
$5.3M
Cancer-Translational Nanotechnology Training Program (Cancer-TNT)T32CA196585 · NCI · STANFORD UNIVERSITY · PI FELSHER, DEAN W, RAO, JIANGHONG · 2015 to 2019
$1.8M
Oncogenic Disruption of the Circadian Metabolic Cycle in CancerK99CA204593 · NCI · WISTAR INSTITUTE · PI ALTMAN, BRIAN JAMES · 2016 to 2017
$173k
Oncogenic Disruption of Circadian Rhythm and ChronotherapyF32CA180370 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ALTMAN, BRIAN JAMES · 2014 to 2015
$113k
NCI NIH HHS F32 CA180370NCI NIH HHS K99 CA204593NCI NIH HHS R01 CA051497NCI NIH HHS R01 CA057341NCI NIH HHS T32 CA196585
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsCell Line, TumorCircadian ClocksHumansLiver NeoplasmsMiceNuclear Receptor Subfamily 1, Group D, Member 1Proto-Oncogene Proteins c-mycTime FactorsMYC protein, humanNR1D1 protein, humanNuclear Receptor Subfamily 1, Group D, Member 1Proto-Oncogene Proteins c-myc

Identifiers

PMID28332504
PMCPMC5376640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.